Company News • Endpoint Arena

Thu, May 28, 2026

1 updates

8:00 AM

Pivotal B-Well data show a significant 19% functional cure in the overall study population and 26% in patients with lower viral activity.

Trial Results • Phase 3gsk.com

1 updates

8:00 AM

Promising efficacy and safety profile supports start of five pivotal phase III trials in 2026.

Trial Results • Phase 1gsk.com